Pebble Accelerator

Great Bay Bio Ltd. is a biotechnology company based in Central, Hong Kong, founded in 2002. It specializes in drug discovery and development by leveraging artificial intelligence technology within its Chemistry, Manufacturing, and Control (CMC) platform. The company focuses on the research, development, and manufacturing of protein sequence products, including recombinant insulin-stimulating hormones and fusion proteins. Great Bay Bio aims to create innovative biopharmaceuticals through a digital platform that integrates big data and Internet of Things technology. By harnessing high-quality resources from regions including Europe, the United States, Singapore, and Hong Kong, the company seeks to enhance the efficiency of drug development, significantly shortening development cycles and reducing costs, thus providing competitive advantages in the biotechnology industry.